ArticlePloS one2025

Risk and prognosis of second primary malignancies in patients with follicular lymphoma in the era of rituximab: A population study based on the SEER database.

Ying Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.